Predictors of Viral Non-Suppression among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study
| Autor: | Roger T. Buju, Pierre Z. Akilimali, Erick N. Kamangu, Gauthier K. Mesia, Jean Marie N. Kayembe, Hippolyte N. Situakibanza |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Adolescent
Anti-HIV Agents Pyridones Health Toxicology and Mutagenesis Public Health Environmental and Occupational Health HIV Infections Viral Load Bunia Piperazines dolutegravir Cohort Studies Oxazines virologic failure Democratic Republic of the Congo HIV-1 Medicine Humans Prospective Studies conflict setting Heterocyclic Compounds 3-Ring |
| Zdroj: | International Journal of Environmental Research and Public Health; Volume 19; Issue 3; Pages: 1085 International Journal of Environmental Research and Public Health, Vol 19, Iss 1085, p 1085 (2022) |
| ISSN: | 1660-4601 |
| Popis: | The Democratic Republic of the Congo adopted the integrase inhibitor dolutegravir (DTG) as part of its preferred first-line HIV treatment regimen in 2019. This study aimed to identify predictors of viral non-suppression among HIV-infected patients under a DTG-based regimen in the context of ongoing armed conflict since 2017 in the city of Bunia in the DRC. We conducted a cohort study of 468 patients living with HIV under DTG in all health facilities in Bunia. We calculated the proportion of participants with an HIV RNA of below 50 copies per milliliter. About three in four patients (72.8%) in this cohort had a viral load (VL) of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|